Penserra Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9K Sell
21
-105
-83% -$45K ﹤0.01% 830
2025
Q1
$60K Sell
126
-548
-81% -$261K ﹤0.01% 833
2024
Q4
$270K Buy
674
+653
+3,110% +$262K ﹤0.01% 687
2024
Q3
$9K Hold
21
﹤0.01% 899
2024
Q2
$10K Hold
21
﹤0.01% 933
2024
Q1
$8K Sell
21
-1,685
-99% -$642K ﹤0.01% 935
2023
Q4
$693K Buy
1,706
+164
+11% +$66.6K 0.01% 447
2023
Q3
$535K Sell
1,542
-448
-23% -$155K 0.01% 488
2023
Q2
$698K Sell
1,990
-101
-5% -$35.4K 0.01% 436
2023
Q1
$657K Buy
2,091
+1,957
+1,460% +$615K 0.01% 444
2022
Q4
$38K Sell
134
-12,471
-99% -$3.54M ﹤0.01% 919
2022
Q3
$3.65M Sell
12,605
-3,094
-20% -$895K 0.1% 168
2022
Q2
$4.42M Sell
15,699
-7,263
-32% -$2.05M 0.12% 164
2022
Q1
$5.99M Buy
22,962
+22,836
+18,124% +$5.96M 0.14% 180
2021
Q4
$27K Buy
126
+6
+5% +$1.29K ﹤0.01% 1186
2021
Q3
$21K Buy
120
+30
+33% +$5.25K ﹤0.01% 1242
2021
Q2
$18K Buy
+90
New +$18K ﹤0.01% 1177
2021
Q1
Sell
-4,278
Closed -$1.01M 1145
2020
Q4
$1.01M Sell
4,278
-9,449
-69% -$2.23M 0.02% 311
2020
Q3
$3.74M Sell
13,727
-12,173
-47% -$3.31M 0.14% 153
2020
Q2
$7.52M Buy
25,900
+24,550
+1,819% +$7.13M 0.39% 85
2020
Q1
$366K Buy
+1,350
New +$366K 0.02% 371
2018
Q3
Sell
-13,005
Closed -$2.21M 758
2018
Q2
$2.21M Buy
+13,005
New +$2.21M 0.14% 113
2017
Q3
Sell
-10,353
Closed -$1.33M 608
2017
Q2
$1.33M Buy
+10,353
New +$1.33M 0.48% 57
2017
Q1
Sell
-218
Closed -$16K 838
2016
Q4
$16K Buy
218
+33
+18% +$2.42K ﹤0.01% 721
2016
Q3
$16K Buy
185
+74
+67% +$6.4K ﹤0.01% 690
2016
Q2
$10K Buy
111
+42
+61% +$3.78K ﹤0.01% 690
2016
Q1
$5 Buy
69
+17
+33% +$1 ﹤0.01% 853
2015
Q4
$7K Buy
+52
New +$7K ﹤0.01% 661